204 related articles for article (PubMed ID: 8944548)
1. In-vivo activity and enzymatic hydrolysis of novel prostaglandin F2 alpha prodrugs in ocular tissues.
Woodward DF; Chan MF; Cheng-Bennett A; Wheeler LA; Chen G; Burke JA; Kharlamb A; Lai RK; Shan T
Exp Eye Res; 1996 Oct; 63(4):411-23. PubMed ID: 8944548
[TBL] [Abstract][Full Text] [Related]
2. Studies on a novel series of acyl ester prodrugs of prostaglandin F2 alpha.
Cheng-Bennett A; Chan MF; Chen G; Gac T; Garst ME; Gluchowski C; Kaplan LJ; Protzman CE; Roof MB; Sachs G
Br J Ophthalmol; 1994 Jul; 78(7):560-7. PubMed ID: 7918269
[TBL] [Abstract][Full Text] [Related]
3. Studies on the ocular hypotensive effects of prostaglandin F2 alpha ester prodrugs and receptor selective prostaglandin analogs.
Woodward DF; Chan MF; Burke JA; Cheng-Bennett A; Chen G; Fairbairn CE; Gac T; Garst ME; Gluchowski C; Kaplan LJ
J Ocul Pharmacol; 1994; 10(1):177-93. PubMed ID: 8207325
[TBL] [Abstract][Full Text] [Related]
4. Ocular penetration and bioconversion of prostaglandin F2alpha prodrugs in rabbit cornea and conjunctiva.
Chien DS; Tang-Liu DD; Woodward DF
J Pharm Sci; 1997 Oct; 86(10):1180-6. PubMed ID: 9344177
[TBL] [Abstract][Full Text] [Related]
5. Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma.
Prasanna G; Carreiro S; Anderson S; Gukasyan H; Sartnurak S; Younis H; Gale D; Xiang C; Wells P; Dinh D; Almaden C; Fortner J; Toris C; Niesman M; Lafontaine J; Krauss A
Exp Eye Res; 2011 Sep; 93(3):256-64. PubMed ID: 21376717
[TBL] [Abstract][Full Text] [Related]
6. Lack of prostaglandin F2 alpha metabolism by human ocular tissues.
Cheng-Bennett A; Poyer J; Weinkam RJ; Woodward DF
Invest Ophthalmol Vis Sci; 1990 Jul; 31(7):1389-93. PubMed ID: 2365570
[TBL] [Abstract][Full Text] [Related]
7. Ocular pharmacokinetics and hypotensive activity of PF-04475270, an EP4 prostaglandin agonist in preclinical models.
Prasanna G; Fortner J; Xiang C; Zhang E; Carreiro S; Anderson S; Sartnurak S; Wu G; Gukasyan H; Niesman M; Nair S; Rui E; Lafontaine J; Almaden CD; Wells P; Krauss A
Exp Eye Res; 2009 Nov; 89(5):608-17. PubMed ID: 19445930
[TBL] [Abstract][Full Text] [Related]
8. The ocular effects of prostaglandins and the therapeutic potential of a new PGF2 alpha analog, PhXA41 (latanoprost), for glaucoma management.
Bito LZ; Stjernschantz J; Resul B; Miranda OC; Basu S
J Lipid Mediat; 1993; 6(1-3):535-43. PubMed ID: 8358014
[TBL] [Abstract][Full Text] [Related]
9. Role of nitric oxide in PGF2 alpha-induced ocular hyperemia.
Astin M; Stjernschantz J; Selén G
Exp Eye Res; 1994 Oct; 59(4):401-7. PubMed ID: 7532135
[TBL] [Abstract][Full Text] [Related]
10. Dose-related effects of prostaglandin F2 alpha isopropylester on intraocular pressure, refraction, and pupil diameter in monkeys.
Crawford KS; Kaufman PL
Invest Ophthalmol Vis Sci; 1991 Mar; 32(3):510-9. PubMed ID: 1878020
[TBL] [Abstract][Full Text] [Related]
11. The ocular pharmacokinetics of eicosanoids and their derivatives. 1. Comparison of ocular eicosanoid penetration and distribution following the topical application of PGF2 alpha, PGF2 alpha-1-methyl ester, and PGF2 alpha-1-isopropyl ester.
Bito LZ; Baroody RA
Exp Eye Res; 1987 Feb; 44(2):217-26. PubMed ID: 3472899
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin F2 alpha effects on intraocular pressure negatively correlate with FP-receptor stimulation.
Woodward DF; Burke JA; Williams LS; Palmer BP; Wheeler LA; Woldemussie E; Ruiz G; Chen J
Invest Ophthalmol Vis Sci; 1989 Aug; 30(8):1838-42. PubMed ID: 2759797
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin F2 alpha and its analogs induce release of endogenous prostaglandins in iris and ciliary muscles isolated from cat and other mammalian species.
Yousufzai SY; Ye Z; Abdel-Latif AA
Exp Eye Res; 1996 Sep; 63(3):305-10. PubMed ID: 8943703
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo evaluations of the metabolism, pharmacokinetics, and bioavailability of ester prodrugs of L-767,679, a potent fibrinogen receptor antagonist: an approach for the selection of a prodrug candidate.
Prueksaritanont T; Gorham LM; Breslin MJ; Hutchinson JH; Hartman GD; Vyas KP; Baillie TA
Drug Metab Dispos; 1997 Aug; 25(8):978-84. PubMed ID: 9280406
[TBL] [Abstract][Full Text] [Related]
15. The effect of prostaglandin F2 alpha on intraocular pressure in normotensive human subjects.
Lee PY; Shao H; Xu LA; Qu CK
Invest Ophthalmol Vis Sci; 1988 Oct; 29(10):1474-7. PubMed ID: 3170119
[TBL] [Abstract][Full Text] [Related]
16. Effects of prostaglandin D2 and its analogues on intraocular pressure in rabbits.
Goh Y; Nakajima M; Azuma I; Hayaishi O
Jpn J Ophthalmol; 1988; 32(4):471-80. PubMed ID: 3236567
[TBL] [Abstract][Full Text] [Related]
17. Effect of the Antiglaucoma Agent JV-GL1 and Related Compounds in the Canine Eye.
Woodward DF; Coleman RA; Woodrooffe AJ; Spada CS; Wang JW
J Ocul Pharmacol Ther; 2020 Oct; 36(8):636-648. PubMed ID: 32640926
[No Abstract] [Full Text] [Related]
18. Prostaglandin F2 alpha isopropyl ester versus iloprost phenacyl ester in rabbit and beagle eyes.
Groeneboer MC; Hoyng PF; Kuizenga A
Curr Eye Res; 1989 Feb; 8(2):131-8. PubMed ID: 2540937
[TBL] [Abstract][Full Text] [Related]
19. Studies on the ocular pharmacology of prostaglandin D2.
Woodward DF; Hawley SB; Williams LS; Ralston TR; Protzman CE; Spada CS; Nieves AL
Invest Ophthalmol Vis Sci; 1990 Jan; 31(1):138-46. PubMed ID: 2298534
[TBL] [Abstract][Full Text] [Related]
20. Effect of topical prostaglandin PGA2, PGA2 isopropyl ester, and PGF2 alpha isopropyl ester on intraocular pressure in normotensive and glaucomatous canine eyes.
Gum GG; Kingsbury S; Whitley RD; Garcia A; Gelatt KN
J Ocul Pharmacol; 1991; 7(2):107-16. PubMed ID: 1919268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
